These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 17576889

  • 1. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer.
    Banki F, Mason RJ, Oh D, Hagen JA, DeMeester SR, Lipham JC, Tanaka K, Danenberg KD, Yacoub WN, Danenberg PV, DeMeester TR.
    Arch Surg; 2007 Jun; 142(6):533-8; discussion 538-9. PubMed ID: 17576889
    [Abstract] [Full Text] [Related]

  • 2. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F, Yacoub WN, Hagen JA, Mason RJ, Ayazi S, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR.
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [Abstract] [Full Text] [Related]

  • 3. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M, Hirahara N, Kinugasa S, Yoshimura H.
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [Abstract] [Full Text] [Related]

  • 5. Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection.
    Ishihara R, Iishi H, Takeuchi Y, Kato M, Yamamoto S, Yamamoto S, Masuda E, Tatsumi K, Higashino K, Uedo N, Tatsuta M.
    Gastrointest Endosc; 2008 May; 67(6):799-804. PubMed ID: 18158151
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer.
    Tomimaru Y, Yano M, Takachi K, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S.
    J Am Coll Surg; 2006 Jan; 202(1):139-45. PubMed ID: 16377507
    [Abstract] [Full Text] [Related]

  • 10. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [Abstract] [Full Text] [Related]

  • 19. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T.
    Oncol Rep; 2003 Dec; 10(2):411-4. PubMed ID: 12579281
    [Abstract] [Full Text] [Related]

  • 20. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.